Literature DB >> 11259972

Australian high-dose-rate brachytherapy protocols for gynaecological malignancy.

C MacLeod1, R Cheuk, M Dally, A Fowler, S Gauden, S Leung, C Milross, K Narayan, M Stevens, D Thornton, S Carruthers, P Jeal.   

Abstract

There is no consensus over the optimal dose fractionation schedules for high-dose-rate (HDR) brachytherapy used for gynaecological malignancy. In Australian public hospital departments of radiation oncology, HDR brachytherapy for gynaecological cancer is being more commonly used. A survey of public departments that are using this technology, or that plan to introduce this technology, was performed. Their current protocols are presented. In general, protocols are similar biologically; however, the practical aspects such as the number of fractions given do vary and may reflect resource restrictions or, alternatively, differences in interpretations of the literature and of the best protocols by clinicians.

Entities:  

Mesh:

Year:  2001        PMID: 11259972     DOI: 10.1046/j.1440-1673.2001.00872.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  2 in total

1.  Patterns of care study of brachytherapy in New South Wales: malignancies of the uterine corpus.

Authors:  Stephen R Thompson; Geoff P Delaney; Gabriel S Gabriel; Michael B Barton
Journal:  J Contemp Brachytherapy       Date:  2015-06-29

2.  Establishment of a New Three-Dimensional Dose Evaluation Method Considering Variable Relative Biological Effectiveness and Dose Fractionation in Proton Therapy Combined with High-Dose-Rate Brachytherapy.

Authors:  Daisuke Kobayashi; Tomonori Isobe; Kenta Takada; Yutaro Mori; Hideyuki Takei; Hiroaki Kumada; Satoshi Kamizawa; Tetsuya Tomita; Eisuke Sato; Hiroshi Yokota; Takeji Sakae
Journal:  J Med Phys       Date:  2019-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.